RZLT Stock Summary and Trading Ideas (Rezolute - Common (Nv) | NASDAQ:RZLT)

Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.

Rezolute - Common (Nv) trades on the NASDAQ stock market under the symbol RZLT.

As of September 23, 2026, RZLT stock price declined to $4.00 with 1,659,947 million shares trading.

RZLT has a beta of 1.03, meaning it tends to be more sensitive to market movements. RZLT has a correlation of 0.00 to the broad based SPY ETF.

RZLT has a market cap of $385.17 million. This is considered a Small Cap stock.

In the last 3 years, RZLT traded as high as $11.46 and as low as $.72.

The top ETF exchange traded funds that RZLT belongs to (by Net Assets): VTI, VXF, VTWO, SCHA, FESM.

RZLT has underperformed the market in the last year with a price return of -53.1% while the SPY ETF gained +16.9%. RZLT has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -18.2% and -1.5%, respectively, while the SPY returned +4.9% and +1.0%, respectively.

RZLT support price is $3.89 and resistance is $4.19 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that RZLT shares will trade within this expected range on the day.